U.S. Paper and Forestry Products Stock News

In February 2026, Tower Semiconductor and partners Salience Labs, Xanadu, and Scintil Photonics announced expanded collaborations to manufacture advanced silicon photonics solutions for AI data centers and photonic quantum computing, moving several programs onto Tower's high-volume platforms and into pre-production readiness. These deals collectively highlight Tower's role as a manufacturing backbone for cutting-edge photonic technologies that could underpin next-generation AI networking and...

If you are wondering whether American Healthcare REIT is attractively priced at around US$52.24, you are not alone. Many investors are asking if the recent run reflects its true value or if there is still room on the table. The stock has returned 0.6% over the last 7 days, 10.6% over the past month, and 80.1% over the past year, which naturally raises questions about how risk and reward now stack up. Recent coverage has focused on American Healthcare REIT as a healthcare focused real estate...

Why General Electric stock is on investors’ radar General Electric (GE) has drawn fresh attention after recent trading, with the share price near $342.26 and returns over the past month and past 3 months outpacing its single day and weekly moves. See our latest analysis for General Electric. That recent 17.02% 1 month share price return and 14.68% 3 month share price return sit alongside a 66.30% 1 year total shareholder return and a very large 5 year total shareholder return. Together, these...

MKS Inc. (NasdaqGS:MKSI) CEO John T.C. Lee is scheduled to appear at Morgan Stanley’s Technology, Media & Telecom Conference. Director Peter Cannone recently sold shares of MKS Inc., according to insider transaction disclosures. The company’s latest disclosed share price is $244.46. MKS Inc. comes into this news with a share price of $244.46 and a 1 year return of 168.2%, alongside a 45.2% return year to date. Over 3 years, the stock shows a 159.4% return and over 5 years a 66.0% return...

Wave Life Sciences has reported its fourth-quarter and full-year 2025 results, with quarterly revenue falling to US$17.24 million from US$83.75 million and the company moving from a net income of US$29.25 million to a net loss of US$53.18 million, while also outlining progress across its RNA-based obesity and alpha-1 antitrypsin deficiency programs. Despite wider losses, Wave highlighted interim obesity and alpha-1 antitrypsin deficiency data, a cash position of US$602.10 million funding...

In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a much smaller net loss of US$21.15 million for the quarter and US$221.25 million for the year, alongside guidance for 2026 that includes expected operating profitability (excluding stock-based compensation) beginning in the third quarter. The company also strengthened its financial position through a US$130 million equity raise, reworked term loans, and ongoing uptake of its VOQUEZNA...

Hershey's President, International has recently sold a substantial block of NYSE:HSY shares. This transaction adds to a wider pattern of insider selling at Hershey over the past year. The continued selling activity is material for investors tracking management sentiment and governance signals. Hershey, the maker of chocolate, confectionery, and snacks under brands many consumers know well, sits at the heart of the packaged food sector. For investors, insider activity at a company like this...

Arbor Realty Trust (ABR) just closed out FY 2025 with Q4 revenue of US$81.3 million and basic EPS of US$0.07, capping a year where trailing twelve month revenue came in at US$467.7 million and EPS at US$0.56. Over recent quarters the company has seen quarterly revenue range from US$111.1 million to US$140.7 million with EPS between US$0.12 and US$0.20, while trailing twelve month revenue has moved between US$467.7 million and US$650.4 million and EPS between US$0.56 and US$1.35. This sets the...

Tutor Perini Corporation recently reported fourth-quarter 2025 results, with sales of US$1,507.37 million and net income of US$28.84 million, and its Board declared a quarterly cash dividend of US$0.06 per share payable on March 26, 2026 to shareholders of record on March 10, 2026. The shift from a net loss in the prior year to profitability for both the quarter and full year highlights a material improvement in operating performance that may influence how investors view the company’s...

Event context and recent share performance Elevance Health (ELV) shares closed at US$320, with the stock showing a 1-day return of 0.94% and a 7-day decline of 6.69%, extending weaker performance over the past month and the past 3 months. See our latest analysis for Elevance Health. Looking beyond this week, Elevance Health’s share price return is weaker over the year, with a year to date share price decline of 9.67% and a 1 year total shareholder return of 17.81% in the red. This suggests...

AvePoint (AVPT) is back in focus after reporting Q4 and full year 2025 earnings, issuing 2026 revenue guidance, and filing a US$206.96 million shelf registration tied to an employee stock ownership plan. See our latest analysis for AvePoint. The earnings beat and AI-focused product updates have coincided with a 3.85% 1 day share price return. However, the 30 day and year to date share price returns of 9.56% and 18.46% declines, and a 27.84% decline in the 1 year total shareholder return,...

Amgen signalled a shift in focus toward growth leadership, backed by strong momentum from products such as Repatha. The company recently guided revenue higher following a strong quarterly update. Investors are watching for Phase 3 data on MariTide, Amgen’s obesity drug candidate, which could influence its growth story. For investors watching NasdaqGS:AMGN, the story is no longer only about dividends and stability. The share price stands at $388.16, with returns of 3.6% over the past week...

Luckin Coffee (OTCPK:LKNC.Y) has surpassed 30,000 stores in China, marking a new scale milestone in its domestic network. The company reports continued growth in overall revenue alongside a slowdown in same-store sales. Profit margins are under pressure as Luckin Coffee invests in rapid expansion and faces rising competition and costs. The brand is also expanding its international footprint, adding to its profile as a global coffee retailer. For investors following consumer and retail...

If you are wondering whether NetScout Systems is priced attractively right now, the recent share performance gives you a useful starting point but not the full story on value. The stock closed at US$29.21, with a 1.6% decline over the last 7 days, a 4.1% gain over 30 days, an 8.8% gain year to date, and a 29.9% return over the past year, while the 3 year and 5 year returns sit at 3.2% and 6.3% respectively. These moves come against a backdrop of ongoing interest in networking and...

Why Avnet Is On Investors’ Screens Right Now Avnet (AVT) has caught investor attention after a period where its shares show mixed short term returns but solid gains over the past 3 months and year to date, prompting fresh questions about valuation and fundamentals. See our latest analysis for Avnet. While Avnet’s share price has eased slightly in the last week, the 30 day share price return of 9.81% and 90 day gain of 38.58% suggest momentum has been building alongside a 1 year total...

Excelerate Energy, Inc. recently reported its fourth-quarter and full-year 2025 results, posting US$317.57 million in quarterly revenue and US$39.2 million in full-year net income, while slightly missing consensus earnings expectations in the final quarter. The company paired these record annual figures with fresh 2026 adjusted EBITDA guidance, updates on its Iraq LNG terminal and Jamaica integration, and a US$0.08 quarterly dividend, underscoring how growth projects and capital commitments...

Vital Farms stock moves after recent performance Vital Farms (VITL) has drawn investor attention after recent share price pressure, with the stock showing negative returns over the past week, month and past 3 months, prompting closer scrutiny of its current valuation. See our latest analysis for Vital Farms. At a share price of $21.09, Vital Farms has seen momentum fade recently, with a 30 day share price return of 25.87% and a 1 year total shareholder return of 36.3%, set against a 3 year...

Levi Strauss (NYSE:LEVI) has agreed to sell its Dockers casualwear business in Peru to Authentic Brands Group. The transaction involves the Dockers brand rights in the Peruvian market and reflects a change in how Levi Strauss manages parts of its portfolio. Investors are watching how the divestiture could reshape Levi Strauss's regional focus and operational footprint. Levi Strauss, best known for its Levi's denim line, has long used Dockers to reach consumers looking for casual, non denim...

If you are wondering whether ACM Research at around US$55.68 is still good value after its big run, you are not alone. This article is designed to help you make sense of what that price might imply. The stock has been volatile recently, with a 16.4% decline over the last 7 days, a 1.8% gain over 30 days, and returns of 24.1% year to date and 114.6% over the past year, while the 3 year return is very large and the 5 year return is 89.6%. Recent attention on semiconductor related names, as...

Trump Media & Technology Group (NasdaqGM:DJT) is in advanced talks to spin off its Truth Social platform into a separate publicly traded company. The possible transaction would follow completion of Trump Media's planned merger with fusion energy firm TAE Technologies. The move would represent a major reshaping of Trump Media's assets across social media and energy businesses. For you as an investor, the headline is that Trump Media & Technology Group, known primarily for its Truth Social...

In February 2026, Axogen reported full-year 2025 results showing sales of US$225.21 million versus US$187.34 million in 2024, alongside a wider net loss of US$15.70 million and basic loss per share of US$0.34, while also issuing 2026 guidance for at least 18% revenue growth to about US$265.70 million with a 74%–76% gross margin range. These results coincided with U.S. FDA approval of Avance as the first biologic for peripheral nerve discontinuities with 12 years of market exclusivity, debt...

A Lyft driver in Detroit has been charged with multiple felony counts, including second-degree murder, following a crash that killed two passengers. The incident involved a Lyft ride that ended in a fatal collision, raising questions about rider safety and driver behavior on the platform. The case brings fresh attention to Lyft's (NasdaqGS:LYFT) safety policies, driver vetting, and potential legal exposure. Lyft operates a rideshare platform that connects riders with drivers, competing...

Cheniere Energy (NYSE:LNG) marks the tenth anniversary of its first LNG export, underscoring a key milestone for the company and the wider U.S. LNG export industry. The company signs a long term LNG sales agreement with CPC Corporation of Taiwan, with contracted deliveries set to run through 2050. Cheniere advances expansion projects at its Corpus Christi and Sabine Pass facilities that are intended to increase liquefaction capacity. Cheniere Energy, a major U.S. LNG exporter, operates...

Delta Air Lines, NYSE:DAL, has placed new orders for 31 next generation Airbus widebody aircraft and 30 Boeing 787-10 jets. The move is part of a broader fleet modernization and international growth initiative focused on long term efficiency and premium service. The expanded widebody order targets global route development and updated cabin products for long haul customers. Delta Air Lines, trading at $65.7, is tying a fresh round of fleet investment to its positioning as a major global...